3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Prostatic Neoplasms
13
Breast Neoplasms
13
Colorectal Neoplasms
8
Obesity
7
Ovarian Neoplasms
6
Motor Activity
5
Malnutrition
5
Rectal Neoplasms
4
Polycystic Ovary Syndrome
4
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Overweight
3
Multiple Myeloma
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Colonic Neoplasms
3
Weight Loss
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Insulin Resistance
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
lutetium Lu 177 dotatate
34
Everolimus
33
lanreotide
13
gallium Ga 68 dotatate
13
Temozolomide
13
Magnetic Resonance Spectroscopy
13
Nivolumab
12
pembrolizumab
11
Octreotide
11
Capecitabine
11
177Lu-octreotide, DOTA(0)-Tyr(3)-
10
cabozantinib
9
Positron Emission Tomography Computed Tomography
9
3-Iodobenzylguanidine
9
surufatinib
8
Sunitinib
8
Specimen Handling
7
Carboplatin
7
pasireotide
6
amino-acid, glucose, and electrolyte solution
6
90Y-octreotide, DOTA-Tyr(3)-
6
lenvatinib
5
Lutetium-177
5
Ipilimumab
5
Fluorodeoxyglucose F18
5
Etoposide
5
Cisplatin
5
Bevacizumab
5
telotristat ethyl
4
olaparib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neuroendocrine Tumors
×
Diet Therapy
×
Clear all
NCT02481804
2024-05-06
DIVIT-pilot
University Medical Center Groningen
Phase NA
Completed
15 enrolled